Evis Sala: Returning Home to Transform Healthcare
Major Win for Childhood Cancer Advocacy: UN Adopts GICC Target
Marty Makary: FDA Rejection Letters are Now Public
Tom Powles: Another Step Towards Curing Bladder Cancer
David Steensma: Ajax Therapeutics Receives Orphan Drug Designation by FDA for AJ1-11095 for the Treatment of Myelofibrosis
FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC
Maryam Lustberg: From Phase 2 Promise to Phase 3 Proof in Neuropathy Prevention
FDA Awarded a National Priority Voucher to Teclistamab with Daratumumab for R/R Multiple Myeloma
"Going Full TILt: challenges, successes, and coordination with administering TIL therapy" is an upcoming "Rx-cited: Clinical Conundrums" roundtable organized by the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task […]
The 2026 ASCO Gastrointestinal Cancers Symposium will take place from January 8–10, 2026, at Moscone West in San Francisco, CA, as well as online. This annual event gathers oncology professionals from around the world to explore the latest developments in GI cancer treatment, research, and patient care. Featuring cutting-edge scientific presentations and multidisciplinary discussions, the […]
The Highlights of ASH in North America is a two-day program offered by the American Society of Hematology (ASH) in multiple locations to explore and discuss the most influential and novel research presented at the latest ASH Annual Meeting. The program is designed to allow hematology leaders and experts to connect in person, learn how […]
The ANCO’s Medicare Regulations Update 2026 webinar on January 14, 2026, will provide a comprehensive overview of the latest Medicare changes affecting oncology services. Bobbi Buell, MBA, will cover updates to the Physician Fee Schedule, coding and billing, evaluation and management, and incentive programs, offering essential insights for clinicians and practice teams. Register here.
The MASCC Webinar “ADCs and Mucositis: From Mechanism to Care” on January 15, 2026, at 8:00 PM UTC+4 will explore the therapeutic potential and toxicity of antibody-drug conjugates (ADCs), with a focus on the recognition, prevention, and management of ADC-induced oral mucositis. Expert speakers, including Prof. Paolo Bossi, Prof. Florian Scotté, Dr. Barbara Pistilli, Dr. […]
The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management, covering topics from diagnosis to treatment, based on current standards of care in a multidisciplinary setting. The preceptorship will take place from January 16–17, 2026, in Milan, Italy. The course is […]
The Cancer Immunotherapy Winter School, hosted by the Society for Immunotherapy of Cancer (SITC), is a hybrid program taking place in Boston and virtually from February 16–18, 2026, with the in-person meeting held at The Westin Copley Place, Boston. The school is tailored for early-to-mid career scientists and clinicians who are new to the field, […]
The 22nd Oncology Updates: Advanced and Controversies Conference, presented by The University of Texas MD Anderson Cancer Center, is an interactive, multidisciplinary forum held from Friday, January 16 to Monday, January 19, 2026, at the Steamboat Grand Hotel in Steamboat Springs, Colorado. The conference is designed to address the rapidly evolving complexities of solid tumor […]
The 2nd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care will be held from January 16 to 18, 2026, in Hollywood, Florida. This premier event brings together a diverse range of oncology professionals including medical oncologists, hematologists, radiation oncologists, and other healthcare providers to explore the latest developments in cancer diagnosis, treatment, and supportive […]
The European Association for Cancer Research (EACR) conference, "Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy," is a Virtual Event scheduled for January 20-21, 2026. This conference explores a paradoxical and radically different approach to cancer therapy: instead of inhibiting the signals that drive cancer, it focuses on the deliberate hyper-activation of oncogenic […]
The Better Breathing Week 2026 is the 43rd annual accredited lung health conference presented by the Lung Health Foundation, scheduled to take place from January 20–24, 2026, both in-person at the Hyatt Regency in Toronto, Canada, and virtually. As one of Canada's leading respiratory medical conferences, it brings together healthcare professionals, researchers, policymakers, and patient […]
The 18th Breast, Gynecological and Immuno‑oncology International Cancer Conference (BGICC 2026) will take place on 22–23 January 2026 at the Hilton Heliopolis Hotel in Cairo, Egypt. Recognized as the largest and most prestigious oncology conference in Africa and the Middle East, BGICC 2026 will bring together leading oncology professionals, researchers, and clinicians to discuss the […]